Stratum Nutrition® Announces Market Ready Dairy Free BLIS K12® and BLIS M18®
Washingtoner/10171227

CARTHAGE, Mo. - Washingtoner -- Stratum Nutrition^®, (a business of ESM Technologies), in conjunction with Blis Technologies, is pleased to announce the release of dairy-free BLIS K12^® and BLIS M18^® to Stratum Nutrition's ingredient science-backed portfolio. Stratum Nutrition is the North American distributor for Blis Technologies. The release of both allergen free ingredients is helpful to customers seeking to formulate dairy free, probiotic lines. Strains are available today to customers with appropriate equivalency data.

Brian Watson, CEO at Blis Technologies said, "We are pleased to offer Stratum customers Dairy Free versions of BLIS K12® and BLIS M18® recognizing that a proportion of consumers may have had allergens to dairy that have prevented them from accessing our probiotic strains. We have partnered with Sacco System, a probiotic fermentation expert, to develop these versions of the strains and provide ongoing supply. It is important to note that we will continue to offer the original versions of both BLIS K12® and BLIS M18® that have been trusted by a wide range of customers over many years."

Blis Technologies has been the scientific leader in oral probiotics since 2002 and they continue to lead the way in oral probiotic supplements. When it comes to a healthy oral cavity, Streptococcus salivarius is the dominant organism present and several strains have been shown to produce favorable bacteriocin-like inhibitory substances (BLIS). Two strains are currently marketed as probiotic ingredients, BLIS K12^® and BLIS M18^®.

More on Washingtoner

• Americans Leave Behind or Discard 42% of Their Belongings When Moving Out for the First Time, Talker Research Finds
• Central Florida Luxury Real Estate Firm DANHOLM COLLECTION Partners with Luxury Presence to Expand Global Buyer Reach
• Advantage Marketing Launches 3-Minute Assessment to Help SMBs Diagnose and Fix Marketing Gaps
• InterMountain Management Announces the Re-opening of Holiday Inn Express & Suites Alexandria
• City Council to Discuss 'Connect Tacoma' Transportation Levy Replacement at April 14 Study Session

BLIS K12^® helps maintain ear, nose, and throat health and supports our natural immune system defenses.* It is safe and effective for children and adults and features a robust research portfolio with over 30 years of published research. BLIS M18^® is a friendly bacteria that can be used in conjunction with regular oral hygiene practices to establish a healthy balance of natural bacteria in the mouth to support healthy teeth and gums and overall health.

Micah Osborne, CEO at Stratum Nutrition^®, "We are proud to be partnered with Blis Technologies as they continue to pursue research to provide high quality probiotic solutions. The BLIS ingredients have been a key part of our proprietary branded ingredient portfolio. We are excited to be able to build on this with the addition of dairy free BLIS K12^® and BLIS M18^®."

For more information about Stratum Nutrition^® and its branded ingredients, please visit www.stratumnutrition.com.

###

About Stratum Nutrition

Stratum Nutrition^®, a business of ESM Technologies, LLC, sustainably provides world class nutrition ingredient solutions to nutritional product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM^® brand eggshell membrane, ESC^® brand eggshell calcium, Ahiflower^® plant-based omegas-3,6,9, Curcumin 95, curQplus™, LBiome™ Lactobacillus LB postbiotic, NatAxtin™ astaxanthin, as well as oral health probiotics, BLIS K12^® and BLIS M18^®. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.

More on Washingtoner

• CB Stuffer Expands New England Footprint with Launch at Common Man Roadside in Hooksett, NH
• Contracting Resources Group Named to the 2026 Inc. Regionals: Mid-Atlantic List
• Dividend Stock Guru Unveils High Yield Dividend Stock Research Reports
• Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
• All American Home Renovators: Transforming Bathrooms into Masterpieces, One Home at a Time

About Blis Technologies

Blis Technologies develops and manufactures the world's first advanced oral probiotics, BLIS K12^® & BLIS M18^®. Based out of New Zealand, Blis Technologies combine innovation with more than 30 years of research to provide delivery probiotic solutions for specific health areas including ears, nose, throat, teeth and gums, and skin care.  Visit www.blis.co.nz for more information.

*These statements have not been evaluated by the U.S. Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.